• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION CLEARLINK I.V. ADMINISTRATION SETS WITH CONTROL-A-FLO REGULATOR; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION CLEARLINK I.V. ADMINISTRATION SETS WITH CONTROL-A-FLO REGULATOR; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 2C8891
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 10/08/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(6).Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that a clearlink system extension set with control-a-flo regulator broke.It was further reported that during a cardiac catheterization procedure, the "control-a-flo regulator on iv extension tubing broke preventing patient from receiving sedative medications, heparin, and iv fluids".The patient also "has some small volume blood loss".The device was "removed and the procedure continued with no further issues".There was no patient injury or medical intervention associated with this event.No additional information is available.
 
Additional Manufacturer Narrative
The device was received for evaluation.During visual inspection, only the tubing part joint which goes into the white site of the regulator was received for evaluation.One part of the assembly was received.The other section was not received.The reported condition was verified.By the nature of the sample, no additional tests could be performed.Therefore, the cause of the condition could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK I.V. ADMINISTRATION SETS WITH CONTROL-A-FLO REGULATOR
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
MDR Report Key9444284
Report Number1416980-2019-06785
Device Sequence Number16666604
Product Code FPA
UDI-Device Identifier00085412046396
UDI-Public(01)00085412046396
Combination Product (Y/N)N
Initial Reporter StateNM
Initial Reporter CountryUS
PMA/510(K) Number
K121634
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date (Section B) 01/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number2C8891
Device Lot NumberDR19F13066
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/17/2020
Initial Date Received by Manufacturer 11/12/2019
Supplement Date Received by Manufacturer01/22/2020
Initial Report FDA Received Date12/10/2019
Supplement Report FDA Received Date01/27/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
HEPARIN; UNSPECIFIED IV FLUIDS; UNSPECIFIED SEDATIVES
Patient Age67 YR
Patient Weight83
-
-